Tiziana Life Sciences Ltdis A Clinical Stage Biotechnology Company Based In Hamiltonbermudathe Company Is Dedicated To Developing Innovative Immunotherapies For Neurodegenerativeneuroinflammatoryand Lung Diseasestiziana Focuses On Alternative Drug Delivery Methods To Enhance Treatment Efficacy And Improve Patient Outcomes The Company S Mission Is To Create Breakthrough Therapies For Conditions Such As Non Active Secondary Progressive Multiple Sclerosisalzheimerae S Diseasealsand Crohnae S Diseasetiziana S Key Products Include Foralumaba Monoclonal Antibody In Clinical Development For Neurodegenerative Diseases And Crohnae S Diseasemilcicliba Small Molecule Inhibitor Targeting Cancer Progressionand Tzls 501An Anti Il 6R Monoclonal Antibody Aimed At Chronic Inflammationtiziana Emphasizes Advanced Delivery Systemssuch As Nasal And Inhalation Routesto Optimize Treatment Precision And Patient Compliance
United States
